Entasis Therapeutics Holdings OverviewEntasis Therapeutics Holdings Net Income
Profitability analysis for ETTX.
Quarterly Net Income
-$15.27M
↓ 42.72% YoY
As of Mar 2022
Annual Net Income (TTM)
-$86.83M
↓ 89.05% YoY
Trailing 12 months ending Mar 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...